Physician profile
Troy Shields
NPI 1285011007
$26,168.57
in general payments reported to CMS, 2019-2025
15 companies · $84.22 in 2025
The $84.22 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22K · 2021: $2,596 · 2022: $177 · 2023: $1,114 · 2024: $197 · 2025: $84.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839 · Travel and Lodging: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.63 |
| Travel and Lodging | $556.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2020 | |
| Smith+Nephew, INC. | $4,056.41 | 2020-2023 | Trigen, Trigen Intertan |
| Stryker Corporation | $1,585.05 | 2021-2023 | Mako, T2 |
| Vericel Corporation | $192.13 | 2021-2024 | Maci |
| Vertex Pharmaceuticals Incorporated | $84.22 | 2025 | |
| Evolution Surgical, INC | $52.76 | 2023-2024 | |
| Relievant Medsystems, INC. | $36.03 | 2023 | Intracept |
| Sanofi-Aventis U.S. LLC | $26.54 | 2023 | |
| Kci USA, INC. | $24.18 | 2023 | Prevena, V.A.C. Veraflo |
| Medtronic, INC. | $24.04 | 2022 | |
| Collegium Pharmaceutical, INC. | $21.07 | 2023 | Xtampza |
| Organogenesis INC. | $19.66 | 2023 | Puraply |
| Heraeus Medical, LLC. | $17.21 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $15.56 | 2022 | |
| Bioventus LLC | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.